No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Omega Therapeutics Faces Leadership Change and Takeover Proposal
Omega Therapeutics Receives Non-binding Proposal From Mirai Bio To Modify Terms Of Research Collaboration Agreement With Novo Nordisk And Pioneering Medicines 08 - Filing
Omega Therapeutics Appoints New Director Ravi Mehrotra
Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines and Montai Therapeutics Under Its Strategic Partnership With Pfizer
Raymond James Downgrades Omega Therapeutics(OMGA.US) to Hold Rating
Raymond James Downgrades Omega Therapeutics to Market Perform From Outperform